Debra Liebert
Director/Board Member at MILESTONE PHARMACEUTICALS INC.
Net worth: 16 001 $ as of 2024-04-29
Profile
Debra K.
Liebert is the founder of Calixa Therapeutics, Inc., Nanothera Corp., Sonexa Therapeutics, Inc., Merada Therapeutics, Inc. She is currently an Independent Non-Executive Director at Milestone Pharmaceuticals, Inc. Her former positions include Executive Director-New Product Management at CancerVax Corp., Managing Director at Domain Associates LLC, Vice President-Corporate Development at Trega Biosciences, Inc., and Vice President-Corporate Development at LPL Technologies, Inc. Liebert holds an MBA from the University of California, Los Angeles, an undergraduate degree from Clarion University of Pennsylvania, and a graduate degree from Duquesne University of The Holy Spirit.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-14 | 10,127 ( 0.02% ) | 16 001 $ | 2024-04-29 |
Debra Liebert active positions
| Companies | Position | Start |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Director/Board Member | 2015-05-31 |
Former positions of Debra Liebert
| Companies | Position | End |
|---|---|---|
| Merada Therapeutics, Inc. | Founder | - |
| Nanothera Corp. | Founder | - |
Sonexa Therapeutics, Inc.
 Sonexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sonexa Therapeutics, Inc. developed drug treatments for Alzheimer's disease (AD) and related disorders. Its lead compound, ST101 had demonstrated both the cognitive benefits of currently marketed AD treatments along with significant disease modifying effects. The company was founded in January 2008 and was headquartered in San Diego, CA. | Founder | - |
Calixa Therapeutics, Inc.
 Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Calixa Therapeutics, Inc. develops and commercializes hospital-based anti-infective therapies. The company was founded by Eckard Weber and James Ge in 2007 and is headquartered in San Diego, CA. | Founder | - |
Trega Biosciences, Inc.
 Trega Biosciences, Inc. BiotechnologyHealth Technology Trega Biosciences, Inc. was a drug discovery company, utilizing combinatorial chemistry and other technologies to pursue the discovery of novel, small-molecule drug therapies. The company leveraged its technology platform by entering into pharmaceutical alliances, enabling partners to access its technologies in exchange for licensing fees and potential milestone payments and royalties or by establishing joint-discovery alliances with biotechnology companies. The company used its drug discovery technologies in its internal development programs. It was headquartered in San Diego, CA. The compnay was acquired by LION bioscience AG | Corporate Officer/Principal | - |
Training of Debra Liebert
| Clarion University of Pennsylvania | Undergraduate Degree |
| Duquesne University of The Holy Spirit | Graduate Degree |
| University of California, Los Angeles | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| Private companies | 8 |
|---|---|
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Finance |
| CancerVax Corp. | Commercial Services |
LPL Technologies, Inc.
 LPL Technologies, Inc. Medical/Nursing ServicesHealth Services LPL Technologies, Inc. develops diagnostic blood tests for gynecological cancer. The company was founded in 1996 by Gordon B. Mills and Michael K. Skinner and is headquartered in Cleveland, OH | Health Services |
Trega Biosciences, Inc.
Trega Biosciences, Inc. BiotechnologyHealth Technology Trega Biosciences, Inc. was a drug discovery company, utilizing combinatorial chemistry and other technologies to pursue the discovery of novel, small-molecule drug therapies. The company leveraged its technology platform by entering into pharmaceutical alliances, enabling partners to access its technologies in exchange for licensing fees and potential milestone payments and royalties or by establishing joint-discovery alliances with biotechnology companies. The company used its drug discovery technologies in its internal development programs. It was headquartered in San Diego, CA. The compnay was acquired by LION bioscience AG | Health Technology |
Calixa Therapeutics, Inc.
Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Calixa Therapeutics, Inc. develops and commercializes hospital-based anti-infective therapies. The company was founded by Eckard Weber and James Ge in 2007 and is headquartered in San Diego, CA. | Health Technology |
| Nanothera Corp. | |
Sonexa Therapeutics, Inc.
Sonexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sonexa Therapeutics, Inc. developed drug treatments for Alzheimer's disease (AD) and related disorders. Its lead compound, ST101 had demonstrated both the cognitive benefits of currently marketed AD treatments along with significant disease modifying effects. The company was founded in January 2008 and was headquartered in San Diego, CA. | Health Technology |
| Merada Therapeutics, Inc. |
- Stock Market
- Insiders
- Debra Liebert
